TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
60,329
|
53,730
|
57,065 |
Financial expenses |
0
![]() |
0
|
2 |
Earnings before taxes |
6,378
|
7,277
|
10,184 |
EBITDA |
6,402
|
7,524
|
10,445 |
Total assets |
15,531
|
20,065
|
23,182 |
Current assets |
13,835
|
19,351
|
22,594 |
Current liabilities |
10,395
|
15,189
|
18,318 |
Equity capital |
5,136
|
4,876
|
4,864 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
14
|
13
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.1%
|
24.3%
|
21.0% |
Turnover per employee |
4,309
|
4,133
|
4,755 |
Profit as a percentage of turnover |
10.6%
|
13.5%
|
17.8% |
Return on assets (ROA) |
41.1%
|
36.3%
|
43.9% |
Current ratio |
133.1%
|
127.4%
|
123.3% |
Return on equity (ROE) |
124.2%
|
149.2%
|
209.4% |
Change turnover |
6,599
|
-3,335
|
2,577 |
Change turnover % |
12%
|
-6%
|
5% |
Chg. No. of employees |
1
![]() |
1
|
2 |
Chg. No. of employees % |
8%
![]() |
8%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.